Clinical trial
Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients…
NCT00399867 · Ludwig-Maximilians - University of Munich, Other · Completed
Key facts
| NCT number | NCT00399867 |
|---|---|
| Title | Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma. |
| Official title | Determination of the Efficacy and Feasibility of Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma - a Phase II Clinical Trial. |
| Lead sponsor | Ludwig-Maximilians - University of Munich, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Simvastatin |
| Enrollment | 30 |
| Start date | Apr 1, 2005 |
| Completion | Apr 1, 2007 |
| First posted | Nov 15, 2006 |
| Last update posted | Dec 20, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: